BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17148030)

  • 1. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
    Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
    Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
    Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
    Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.
    Lamers CH; Willemsen RA; van Elzakker P; van Krimpen BA; Gratama JW; Debets R
    Cancer Gene Ther; 2006 May; 13(5):503-9. PubMed ID: 16282986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
    Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL
    Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression.
    Lamers CH; Gratama JW; Pouw NM; Langeveld SC; Krimpen BA; Kraan J; Stoter G; Debets R
    Hum Gene Ther; 2005 Dec; 16(12):1452-62. PubMed ID: 16390276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield.
    Lamers CH; van Elzakker P; van Steenbergen SC; Sleijfer S; Debets R; Gratama JW
    Cytotherapy; 2008; 10(4):406-16. PubMed ID: 18574773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
    Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
    Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
    Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo.
    Lamers CH; Langeveld SC; Groot-van Ruijven CM; Debets R; Sleijfer S; Gratama JW
    Cancer Immunol Immunother; 2007 Dec; 56(12):1875-83. PubMed ID: 17479266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes.
    Lamers CH; Sleijfer S; Willemsen RA; Debets R; Kruit WH; Gratama JW; Stoter G
    J Biol Regul Homeost Agents; 2004; 18(2):134-40. PubMed ID: 15471217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.
    Altenschmidt U; Klundt E; Groner B
    J Immunol; 1997 Dec; 159(11):5509-15. PubMed ID: 9548491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells.
    Hiasa A; Hirayama M; Nishikawa H; Kitano S; Nukaya I; Yu SS; Mineno J; Kato I; Shiku H
    Gene Ther; 2008 May; 15(9):695-9. PubMed ID: 18288212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production.
    Weijtens ME; Hart EH; Bolhuis RL
    Gene Ther; 2000 Jan; 7(1):35-42. PubMed ID: 10680014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
    Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
    Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
    Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
    Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.
    Nguyen TH; Loux N; Dagher I; Vons C; Carey K; Briand P; Hadchouel M; Franco D; Jouanneau J; Schwall R; Weber A
    Cancer Gene Ther; 2003 Nov; 10(11):840-9. PubMed ID: 14605670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.